{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:58:30Z","timestamp":1791280710898,"version":"4.1.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1212\/wnl.51.4.1140","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T09:36:31Z","timestamp":1336901791000},"page":"1140-1145","source":"Crossref","is-referenced-by-count":164,"title":["Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy"],"prefix":"10.1212","volume":"51","author":[{"given":"M. J.","family":"van den Bent","sequence":"first","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Kros","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Heimans","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. C.","family":"Pronk","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.","family":"van Groeningen","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.G.J.","family":"Krouwer","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. J.B.","family":"Taphoorn","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. A.","family":"Zonnenberg","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Tijssen","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Twijnstra","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. J.A.","family":"Punt","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Boogerd","sequence":"additional","affiliation":[{"name":"From the Departments of Neuro-oncology and Medical Oncology (Drs. van den Bent and Pronk), Dr. Daniel den Hoed Cancer Center, Rotterdam; Department of Pathology (Dr. Kros), University Hospital Dijkzigt, Rotterdam; Department of Neurology and Medical Oncology (Drs. Heimans and van Groeningen), University Hospital Vrije Universiteit, Amsterdam; Department of Neurology and Internal Medicine (Drs. Krouwer, Taphoorn, and Zonnenberg), University Hospital Utrecht; Department of Neurology (Dr. Tijssen), St...."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Dutch Neuro-oncology Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"2","volume":"12","year":"1994","unstructured":"Cairncross G, Macdonald D, Ludwin S, et al. Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 1994;12:2013-2021.","journal-title":"J Clin Oncol"},{"key":"e_1_3_1_3_2","first-page":"2","volume":"48","year":"1991","unstructured":"Cairncross JG, Macdonald DR. Chemotherapy for oligodendroglioma. Arch Neurol 1991;48:225-227.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_4_2","first-page":"3","volume":"32","year":"1993","unstructured":"Kyritsis AP, Yung WKA, Bruner J, Gleason MJ, Levin VA. The treatment of anaplastic oligodendrogliomas and mixed gliomas. Neurosurgery 1993;32:365-371.","journal-title":"Neurosurgery"},{"key":"e_1_3_1_5_2","first-page":"7","volume":"76","year":"1992","unstructured":"Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. J Neurosurg 1992;76:741-745.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_6_2","first-page":"1","volume":"30","year":"1996","unstructured":"Soffietti R, Borgogne M, Bradac GB, Schiffer D. Role of chemotherapy in oligodendroglial tumors: a review of the experience at the University of Torino. J Neurooncol 1996;30:153. Abstract.","journal-title":"J Neurooncol"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.2"},{"key":"e_1_3_1_8_2","unstructured":"Duffau H Albuquerque L Ameri A Sanson M Poisson M Delattre J-Y. Chemotherapy for newly diagnosed and recurrent anaplastic oligodendrogliomas and mixed gliomas: an analysis of 42 cases. Neurology 1995;45(suppl 4):A261. Abstract."},{"key":"e_1_3_1_9_2","unstructured":"Brown M Cairncross JG Vick NA et al. Differential response of recurrent oligodendrogliomas versus astrocytomas to intravenous (IV) melphalan. Neurology 1990;40(suppl 1):397. Abstract."},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.1.1"},{"key":"e_1_3_1_11_2","unstructured":"A practical guide to EORTC studies. Brussels: EORTC 1996:131."},{"key":"e_1_3_1_12_2","first-page":"8","volume":"78","year":"1996","unstructured":"Bakardjiev AI, Barnes PD, Goumnerova LC, et al. Magnetic resonance imaging changes after sterotactic radiation therapy for childhood low-grade astrocytoma. Cancer 1996;78:864-873.","journal-title":"Cancer"},{"key":"e_1_3_1_13_2","first-page":"3","volume":"52","year":"1997","unstructured":"Norris AM, Carrington BM, Slevin NJ. Late radiation change in the CNS: MR imaging following gadolinium enhancement. Clin Radiol 1997;52:356-362.","journal-title":"Clin Radiol"},{"key":"e_1_3_1_14_2","first-page":"5","volume":"30","year":"1994","unstructured":"Gannett DE, Wisbeck WM, Silbergeld DL, Berger MS. The role of postoperative irradiation in the treatment of oligodendroglioma. Int J Radiat Oncol Biol Phys 1994;30:567-573.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"60","year":"1987","unstructured":"Bullard DE, Rawlings CE III, Phillips B, et al. Oligodendroglioma: an analysis of the value of radiation therapy. Cancer 1987;60:2179-2188.","journal-title":"Cancer"},{"key":"e_1_3_1_16_2","first-page":"8","volume":"63","year":"1985","unstructured":"Mork SJ, Lindegaard K-F, Halvorsen TB, et al. Oligodendroglioma: incidence and biological behavior in a defined population. J Neurosurg 1985;63:881-889.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<1::AID-CNCR1>3.0.CO;2-R"},{"key":"e_1_3_1_18_2","first-page":"4","volume":"76","year":"1992","unstructured":"Shaw EG, Scheithauer BW, O'Fallon JR, Tazelaar HD, Davis DH. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992;76:428-434.","journal-title":"J Neurosurg"},{"key":"e_1_3_1_19_2","first-page":"2","volume":"33","year":"1997","unstructured":"Krouwer HGJ, van Duinen SG, Kamphorst W, van der Valk P, Algra A. Oligoastrocytomas: a clinicopathological study of 52 cases. J Neurooncol 1997;33:223-238.","journal-title":"J Neurooncol"},{"key":"e_1_3_1_20_2","first-page":"1","volume":"145","year":"1994","unstructured":"Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175-1190.","journal-title":"Am J Pathol"},{"key":"e_1_3_1_21_2","first-page":"9","volume":"54","year":"1995","unstructured":"Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995;54:91-95.","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320703"},{"key":"e_1_3_1_23_2","first-page":"3","volume":"303","year":"1983","unstructured":"Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature 1983;303:390-396.","journal-title":"Nature"},{"key":"e_1_3_1_24_2","first-page":"S","volume":"35","year":"1997","unstructured":"Wang Y, Hagel C, Hamel W, Kluwe L, Westphal M. Trk family members: potential lineage markers for glia. J Neurooncol 1997;35:S47. Abstract.","journal-title":"J Neurooncol"},{"key":"e_1_3_1_25_2","first-page":"S","volume":"35","year":"1997","unstructured":"Luider Th, van den Bent MJ, Smitt PS, Vecht ChJ, Kros JM. Inventory of proteins in astrocytoma and oligodendroglioma by two-dimensional electrophoresis. J Neurooncol 1997;35:S28. Abstract.","journal-title":"J Neurooncol"},{"key":"e_1_3_1_26_2","first-page":"2","volume":"82","year":"1985","unstructured":"Brent TP, Houghton PJ, Houghton JA. O6-alkylguanine-DNA alkyltransferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-(trans-4-methylcyclohexyl)-1-nitrosourea. Proc Natl Acad Sci USA 1985;82:2985-2989.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100118839"},{"key":"e_1_3_1_28_2","first-page":"5","volume":"56","year":"1996","unstructured":"LeDoux SP, Williams BA, Hollensworth BS, et al. Glial cell-specific differences in repair of O6-methylguanine. Cancer Res 1996;56:5615-5619.","journal-title":"Cancer Res"},{"key":"e_1_3_1_29_2","first-page":"4","volume":"69","year":"1996","unstructured":"Mineura K, Yanagisawa T, Watanabe K, Kowada M, Yasui N. Human brain tumor O6-methylguanine-DNA methyltransferase mRNA and its significance as an indicator of selective chloroethylnitrosourea chemotherapy. Int J Cancer 1996;69:420-425.","journal-title":"Int J Cancer"},{"key":"e_1_3_1_30_2","first-page":"3","volume":"53","year":"1993","unstructured":"Silber JR, Mueller BA, Eweres TG, Berger MS. Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and in adjacent normal brain. Cancer Res 1993;53:3416-3420.","journal-title":"Cancer Res"},{"key":"e_1_3_1_31_2","first-page":"3","volume":"15","year":"1997","unstructured":"Chamberlin MC, Kormanik PA. Salvage chemotherapy with taxol for recurrent oligodendrogliomas. J Clin Oncol 1997;15:3427-3432.","journal-title":"J Clin Oncol"},{"key":"e_1_3_1_32_2","first-page":"5","volume":"85","year":"1996","unstructured":"Peterson K, Paleologos N, Forsyth P, Macdonald DR, Cairncross JG. Salvage chemotherapy for oligodendroglioma. J Neurosurg 1996;85:597-601.","journal-title":"J Neurosurg"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.4.1140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:41:15Z","timestamp":1711536075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.4.1140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,10]]}},"alternative-id":["10.1212\/WNL.51.4.1140"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.4.1140","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}